LEE'S PHARM (00950.HK) issued a profit warning, expecting the net profit for the 2024 fiscal year to be between 83 million and 0.106 billion yuan, compared to 17 million yuan recorded in the previous year. This is mainly benefited from the sales growth of products included in the latest pharmaceutical catalog alongside selected products in the pharmaceutical procurement program, with significant improvement in sales revenue throughout the year; optimizing the research and development portfolio has led to reduced research and development costs; and optimizing management has saved costs.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
《盈喜》李氏大藥廠(00950.HK)預計純利大升 全年最少賺8,300萬元
According to "Profit Alert," LEE'S PHARM (00950.HK) expects a significant increase in net profit, projecting to earn at least 83 million yuan for the whole year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 396
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report